Entity

Time filter

Source Type


Wheeler D.S.,Kindervelt Laboratory for Critical Care Medicine Research | Wheeler D.S.,University of Cincinnati | Giuliano J.S.,Kindervelt Laboratory for Critical Care Medicine Research | Lahni P.M.,Kindervelt Laboratory for Critical Care Medicine Research | And 5 more authors.
Advances in Pharmacological Sciences | Year: 2011

Albumin appears to have proinflammatory effects in vitro. We hypothesized that albumin would induce a state of tolerance to subsequent administration of lipopolysaccharide (LPS) in vitro and in vivo. RAW264.7 and primary peritoneal macrophages were treated with increasing doses of bovine serum albumin (BSA) and harvested for NF-B luciferase reporter assay or TNF- ELISA. In separate experiments, RAW264.7 cells were preconditioned with 1mg/mL BSA for 18h prior to LPS (10g/mL) treatment and harvested for NF-B luciferase reporter assay or TNF- ELISA. Finally, C57Bl/6 mice were preconditioned with albumin via intraperitoneal administration 18h prior to a lethal dose of LPS (60mg/kg body wt). Blood was collected at 6h after LPS administration for TNF- ELISA. Albumin produced a dose-dependent and TLR-4-dependent increase in NF-B activation and TNF- gene expression in vitro. Albumin preconditioning abrogated the LPS-mediated increase in NF-B activation and TNF- gene expression in vitro and in vivo. The clinical significance of these findings remains to be elucidated. Copyright © 2011 Derek S. Wheeler et al. Source

Discover hidden collaborations